ODT Staff01.11.24
The orthopedic device landscape is undergoing a seismic shift, fueled by a surge in mergers and acquisitions. Specialized players are being absorbed by industry leaders, driven by a desire for new technologies, expanded markets, and enhanced capabilities.
To navigate this transformative year, we've launched this dedicated resource - your essential guide to every major orthopedic design and technology M&A deal. Stay ahead of the curve, track key partnerships, and understand the industry's reshaping with concise updates and insightful analysis. Return to this page and prepare to witness the future of the orthopedic device industry unfold, transaction by transformative transaction.
Date of Announcement: April 10, 2024
Value: Undisclosed
Date of Announcement: February 13, 2024
Value: Undisclosed
Date of Announcement: January 10 2024
Value: $180 million on completion, with up to a further $150 million contingent on future financial performance
Date of Announcement: January 8, 2024
Value: undisclosed
To navigate this transformative year, we've launched this dedicated resource - your essential guide to every major orthopedic design and technology M&A deal. Stay ahead of the curve, track key partnerships, and understand the industry's reshaping with concise updates and insightful analysis. Return to this page and prepare to witness the future of the orthopedic device industry unfold, transaction by transformative transaction.
HealthpointCapital—SteriCUBE Holdings Inc.
HealthpointCapital, a private equity firm, acquired a majority stake in SteriCUBE Holdings, Inc. and appointed Chris Whitmore CEO.Date of Announcement: April 10, 2024
Value: Undisclosed
Zeda Health—The Orthopaedic Implant Company (OIC)
The acquisition of the high-value trauma implant maker fortifies Zeda's position in the global orthopedic industry as a firm developing and using leading design and manufacturing technologies.Date of Announcement: February 13, 2024
Value: Undisclosed
Smith+Nephew—CartiHeal
Smith+Nephew, the global medical technology company, acquired CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee.Date of Announcement: January 10 2024
Value: $180 million on completion, with up to a further $150 million contingent on future financial performance
OrthoPediatrics—Boston Orthotics & Prosthetics
OrthoPediatrics acquired Boston Orthotics & Prosthetics, a company that has focused on pediatric orthotic management for more than 50 years.Date of Announcement: January 8, 2024
Value: undisclosed